Back
ESC Premium Access

Effectiveness and safety of rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and heart failure

Session: Poster Session 5 - Atrial fibrillation - Stroke prevention 3
Topic: Oral Anticoagulation
Speaker: Doctor C. Coleman (Storrs, US)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Craig Coleman

University of Connecticut, Storrs (United States of America)
10 presentations
0 follower

9 more presentations in this session

Comparison of ischemic stroke risk in atrial fibrillation patients with or without myocardial infarction: A propensity score matched study

Speaker: Doctor G. Yoon (Incheon, KR)

Access
Abstract
Thumbnail

Prognostic impact of inappropriate doses of direct oral anticoagulants in clinical practice: a subanalysis of the FANTASIIA registry, a prospective, nationwide, real-world, observational study.

Speaker: Doctor M. Ruiz Ortiz (Cordoba, ES)

Access
Abstract
Slides
Thumbnail

Incidence of incomplete surgical left atrial appendage closure

Speaker: Assistant Professor Y. Kim (GangNeung, KR)

Access
Abstract
Slides
Thumbnail

Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes in the daily practice

Speaker: Doctor T. Chao (Taipei, TW)

Access
Abstract
Thumbnail

The individual stroke risk in patients with atrial fibrillation

Speaker: Doctor C. Lee (Copenhagen, DK)

Access
Abstract
Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation - Stroke prevention 3

Speakers: Doctor C. Coleman, Doctor G. Yoon, Doctor M. Ruiz Ortiz, Assistant Professor Y. Kim, Doctor T. Chao...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb